Beroni Group (Beroni Group) Change In Receivables : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Beroni Group Change In Receivables?

Beroni Group's change in receivables for the quarter that ended in Jun. 2023 was $0.00 Mil. It means Beroni Group's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

Beroni Group's change in receivables for the fiscal year that ended in Dec. 2022 was $0.00 Mil. It means Beroni Group's Accounts Receivable stayed the same from Dec. 2021 to Dec. 2022 .

Beroni Group's Accounts Receivable for the quarter that ended in Jun. 2023 was $0.43 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Beroni Group's Days Sales Outstanding for the six months ended in Jun. 2023 was 289.85.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Beroni Group's liquidation value for the six months ended in Jun. 2023 was $-0.59 Mil.

Beroni Group Change In Receivables Historical Data

The historical data trend for Beroni Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beroni Group Change In Receivables Chart

Beroni Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

Beroni Group Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Receivables	Get a 7-Day Free Trial									-	-	-	-	-

Beroni Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Beroni Group (OTCPK:BNIGF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Beroni Group's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.432	/	0.272	*	91
=	289.85

2. In Ben Graham's calculation of liquidation value, Beroni Group's accounts receivable are only considered to be worth 75% of book value:

Beroni Group's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.393	-	2.385	+	0.75 * 0.432	+	0.5 * 0.152
=	-0.59

Beroni Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of Beroni Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Beroni Group (Beroni Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Beroni Group Ltd (OTCPK:BNIGF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhong Bei High Technology Industrial Park, Level 10, Building 11, Xiqing District, Tianjin, CHN, 300380

Website

https://www.beronigroup.com

Beroni Group Ltd is an Australia based company engaged in the sale of smoking control product (NicoBloc), air purifier, healthcare products and supplements, cosmetics and stem-cell therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Its operating segment includes Nicobloc, Fogibloc air purifier, Olansi water filter, Health supplements, Cosmetic products, Viral diagnostic kits, and Technical advisory service. Geographically, it operates in China and Japan. The highest revenue is generated from the Nicobloc segment through the China region.